These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 1999084

  • 1. Current options for the treatment of systemic scleroderma.
    McGee BA, Barnett MD, Small RE.
    Clin Pharm; 1991 Jan; 10(1):14-25. PubMed ID: 1999084
    [Abstract] [Full Text] [Related]

  • 2. Severe organ involvement in systemic sclerosis with diffuse scleroderma.
    Steen VD, Medsger TA.
    Arthritis Rheum; 2000 Nov; 43(11):2437-44. PubMed ID: 11083266
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Systemic sclerosis/scleroderma: a treatable multisystem disease.
    Hinchcliff M, Varga J.
    Am Fam Physician; 2008 Oct 15; 78(8):961-8. PubMed ID: 18953973
    [Abstract] [Full Text] [Related]

  • 5. Systemic sclerosis (scleroderma). Clinical management of its major complications.
    Legerton CW, Smith EA, Silver RM.
    Rheum Dis Clin North Am; 1995 Feb 15; 21(1):203-16. PubMed ID: 7732169
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Severe gastrointestinal involvement in systemic sclerosis: report of five cases and review of the literature.
    Jaovisidha K, Csuka ME, Almagro UA, Soergel KH.
    Semin Arthritis Rheum; 2005 Feb 15; 34(4):689-702. PubMed ID: 15692963
    [Abstract] [Full Text] [Related]

  • 8. Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis.
    Steen VD, Medsger TA.
    Arthritis Rheum; 1998 Sep 15; 41(9):1613-9. PubMed ID: 9751093
    [Abstract] [Full Text] [Related]

  • 9. Treatment of mixed connective tissue disease.
    Kim P, Grossman JM.
    Rheum Dis Clin North Am; 2005 Aug 15; 31(3):549-65, viii. PubMed ID: 16084325
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cardiac complications of systemic sclerosis.
    Kahan A, Coghlan G, McLaughlin V.
    Rheumatology (Oxford); 2009 Jun 15; 48 Suppl 3():iii45-8. PubMed ID: 19487224
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Raynaud's phenomenon and scleroderma.
    Harper FE, LeRoy EC.
    Compr Ther; 1981 Feb 15; 7(2):45-51. PubMed ID: 6163587
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of systemic sclerosis.
    Medsger TA.
    Rheum Dis Clin North Am; 1989 Aug 15; 15(3):513-31. PubMed ID: 2672135
    [Abstract] [Full Text] [Related]

  • 17. Vascular complications of scleroderma.
    Guiducci S, Giacomelli R, Cerinic MM.
    Autoimmun Rev; 2007 Sep 15; 6(8):520-3. PubMed ID: 17854742
    [Abstract] [Full Text] [Related]

  • 18. [Non SLE connective tissue diseases: general aspects and kidney].
    Doria A, Sabadini E, Sinico RA.
    G Ital Nefrol; 2005 Sep 15; 22 Suppl 33():S11-20. PubMed ID: 16419000
    [Abstract] [Full Text] [Related]

  • 19. Management of scleroderma in a New Zealand tertiary rheumatology centre: emphasis on pulmonary complications.
    Ng K, Gow P.
    N Z Med J; 2007 May 18; 120(1254):U2537. PubMed ID: 17515941
    [Abstract] [Full Text] [Related]

  • 20. Treatment of systemic sclerosis complications: what to use when first-line treatment fails--a consensus of systemic sclerosis experts.
    Walker KM, Pope J, participating members of the Scleroderma Clinical Trials Consortium (SCTC), Canadian Scleroderma Research Group (CSRG).
    Semin Arthritis Rheum; 2012 Aug 18; 42(1):42-55. PubMed ID: 22464314
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.